Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · $76.2B
After-hours $739.46+0.63%
Price
$649.8
$734.8
Jul 6, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$4.5B+4.6%
6/'26 vs prev quarter
Company Health
Market Cap$76.2B
Operating Margin+24.7%
Cash on Hand$8.0B10.5% of market cap
Free Cash Flow$3.8B4.9% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR4.9xmedian 11.7xPER17.5xmedian 14.9xPBR1.9xmedian 2.1xROE+11.2%median -54.5%
